First Iranian consensus on use of vitamin D in patients with multiple sclerosis published in BMC Neurology
Accumulating evidences from experimental, epidemiologic and clinical studies support the potential linkage between poor vitamin D status and the risk of developing Multiple Sclerosis (MS), as well as, an adverse disease course. However, the results of the trials on the clinical outcomes of vitamin D supplementation in MS patients are less consistent which brought many discrepancies in routine practice. In this article we presented a summary of a symposium on vitamin D and MS.
New research looking at the risk factors contributing to stroke burden — the number of healthy life-years lost due to stroke — has shown that behavioral factors play a larger role than metabolic factors."Poor diet, smoking, alcohol, lack of exercise, et cetera, are responsible for more days of stroke disability than factors such as hypertension, hyperglycemia, high cholesterol, et cetera. Our data show that stroke is definitely a disease of lifestyle, and as such a great proportion of stroke disability can be avoided.
Aura Symptoms Highly Variable in Patients With Migraine
What does migraine aura look like? And how do these visual manifestations differ between patients and in the same patient?These questions have intrigued neurologists for years, but getting clear-cut information has been difficult because most reports of migraine characteristics are retrospective — when asked, patients report details of their attack and how they felt after the fact.But now, researchers are delving deeper into the issue by using prospectively gathered reports and are turning up some surprising findings.
Zika is a viral disease transmitted by Aedes Mosquitoes. There are multiple neurologic manifestations of this condition. The South American epidemic has special features. WHO has reevaluated the risks and has issued an information sheet on May 12th regarding the Olympics in Rio de Janeiro. We are happy to announce that last minute 4 eminent speakers in the field agreed to cover the topic in an additional “breaking news” session on Sunday morning. They will address and answer the questions why European Neurologists should know about this new disease group.